Leap Therapeutics
LPTX
$2.43
Share price
2.97%
Change (1 day)
161.29%
Change (1 year)
Categories
Leap Therapeutics (LPTX) - P/B ratio
P/B ratio as of June 2024 : 1.91
According to Leap Therapeutics
's latest financial reports the company has a price-to-book ratio of 1.91.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Leap Therapeutics - P/B ratio (from 2014 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.76 | 132.77% |
| 2022-12-31 | 0.7570 | -71.46% |
| 2021-12-31 | 2.65 | -7.82% |
| 2020-12-31 | 2.88 | -118.57% |
| 2019-12-31 | -15.5 | -583.41% |
| 2018-12-31 | 3.21 | -53.78% |
| 2017-12-31 | 6.93 | -3041.41% |
| 2016-12-31 | -0.2357 | -23.51% |
| 2015-12-31 | -0.3082 | -112% |
| 2014-12-31 | 2.57 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.83 | -3.90% | 🇺🇸 USA |